Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 42708-191
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 42708-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label (42708 191 30 Label.jpg)
Figure1 (Figure1)
This text contains statistical information regarding a clinical trial or study. It provides data such as cumulative incidences, confidence intervals, and p-values for different groups or treatments. The number at risk for each group is also presented. The format seems to list the results for two different groups or treatments (HR0.56 for one group and placebo for the other).*
Figure2 (Figure2)
The text provides data on a study comparing the effects of Rosuvastatin 20mg versus placebo on cardiovascular events. The study involved 8901 participants and evaluated various endpoints including major cardiovascular events, cardiovascular death, stroke, myocardial infarction, and angina. The results show significant risk reductions with Rosuvastatin compared to placebo for most endpoints, suggesting a potential benefit in reducing cardiovascular risk.*
Figure3 (Figure3)
This appears to be a list of different types of statin medications and their respective doses in milligrams. The medications listed are Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The doses listed include 10mg, 20mg, 40mg, and 80mg for each medication. This information can be useful for healthcare professionals or individuals looking to understand the different options and doses available for statin therapy.*
Logo (Logo)
The text provided is "glenmark" which likely refers to Glenmark Pharmaceuticals, a global pharmaceutical company headquartered in Mumbai, India. Glenmark specializes in the discovery, development, manufacturing, and marketing of a wide range of pharmaceutical products including generic medicines, active pharmaceutical ingredients (APIs), and innovative drugs. With a presence in numerous countries, Glenmark contributes to healthcare by providing affordable and high-quality medications.*
Logo1 (Logo1)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.